Title : DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.

Pub. Date : 2015 Sep

PMID : 25782327






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan. Irinotecan dihydropyrimidine dehydrogenase Homo sapiens
2 Single nucleotide polymorphisms (SNPs) in DPYD and UGT1A1 influence fluoropyrimdines and irinotecan adverse events (AEs). Irinotecan dihydropyrimidine dehydrogenase Homo sapiens